Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...

The running back position is one of the 2025 NFL Draft’s deepest classes on the offensive side of the ball, boasting ...

We recently published an article titled Jim Cramer’s Thoughts On These 8 Stocks and the Packaged Goods Playbook. In this ...

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...

StockNews.com upgraded shares of Universal Electronics (NASDAQ:UEIC – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Monday morning. Several other ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $215.8, along ...

BMY is looking to turn its business around, banking on the strong uptake of new drugs. The recent spate of positive ...

Shares in Universal Music, the world's largest record label, could soon be listed on a U.S. exchange, as a result of a $500 million stock offering by Bill Ackman's Pershing Square. The hedge-fund ...

Such companies can be wonderful options for income-seeking investments. If you're in the market for that combo, let's ...

Though things are looking up for Akero, the stock still looks risky. Akero Therapeutics is developing efruxifermin as a ...